Article Information
History
- April 23, 2021.
Article Versions
- You are currently viewing Version 1 of this article (April 23, 2021 - 02:44).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Farhaan S. Vahidy, PhD MBBS MPH*,1,
- Lauren Pischel, MD2,
- Mauricio E. Tano, PhD1,3,
- Alan P. Pan, MS1,
- Marc L. Boom, MD4,
- Henry Dirk Sostman, MD4,5,
- Khurram Nasir, MD MSC MPH1 and
- Saad B. Omer, MBBS MPH PhD2,6,7,8
- 1Center for Outcomes Research, Houston Methodist, Houston, TX
- 2Yale School of Medicine, Department of Medicine, Section of Infectious Diseases, New Haven, CT
- 3Department of Nuclear Engineering, Texas A&M University, College Station, TX
- 4Houston Methodist Academic Institute, Houston Methodist, Houston, TX
- 5Weill Cornell Medicine, Weill Cornell, New York, NY
- 6Yale School of Public Health, New Haven, CT
- 7Yale Institute of Global Health, New Haven, CT
- 8Yale School of Nursing, Orange, CT
- ↵*Corresponding author:
Farhaan S. Vahidy, PhD MBBS MPH FAHA, Associate Professor and Associate Director, Center for Outcomes Research, Houston Methodist, 7550 Greenbriar Drive, Suite 4.123, Houston Methodist Josie Roberts Building Houston, TX 77030, Office Phone: 346.356.1479, fvahidy{at}houstonmethodist.org
Posted April 23, 2021.
Real World Effectiveness of COVID-19 mRNA Vaccines against Hospitalizations and Deaths in the United States
